Rising cases of mucormycosis throws up another challenge in the second wave
A concerned Health Ministry has now asked all States to classify mucormycosis, a fungal infection, as a notifiable disease under
Read More
SARS-CoV-2
Serum’s supply to COVAX hit by India’s poor vaccination planning
On August 7, a week before Mr. Modi’s announcement, the Pune-based Serum Institute signed an agreement with GAVI and Gates
Read More
Vaccine shortage will affect all eligible groups
The two private vaccine manufacturers — Serum Institute and Bharat Biotech — are required to supply 50% of vaccine produced
Read More
Covaxin offers protection against double mutant (B.1.617) variant
A preprint of the study carried out by ICMR and Bharat Biotech researchers has been posted in biorXiv. Preprints are
Read More
India sets a dangerous precedent with COVID-19 vaccination programme
A large percentage of those aged 18-44 years does not have the resources to pay for vaccines and hence will
Read More
COVID-19: Can vaccination of all adults slow down the second wave in India?
While Maharashtra is still reporting the most cases daily, there has been a slip dip in the last few days.
Read More
COVID-19: Serum refuses to address differential pricing for Central and State governments
The statement tried to address the controversy over whether the price of the vaccines at Rs 600 (nearly $8) per
Read More
India will have 8-10 lakh cases a day when second wave peaks in mid-May, says Bhramar Mukherjee
Since April 1, the number of daily cases has been accelerating at a rapid speed. Can it be any reason
Read More
Zydus Cadila’s antiviral drug for moderate COVID-19 disease gets emergency use approval
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered
Read More
Preliminary study shows Covishield protects against double mutant variant
“Both Covishield vaccinated sera and convalescent sera were found to offer protection against the double mutant variant (B.1.617),” says Dr.
Read More
India promotes vaccine inequity in the midst of the pandemic
The April 19 announcement of the roll-out of vaccines in the third phase, wherein anyone above 18 years is eligible
Read More
EMA wants warning of blood clots with low platelet count for Johnson and Johnson vaccine
In a press release, the EMA said that it found “possible link to very rare cases of unusual blood clots
Read More
COVID-19: India ill prepared despite lessons learnt in the first wave
Precious time was wasted before critical facilities began to be scaled up to meet the demands of the second wave
Read More